Top Markets
Coin of the day
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc.

TALS
Rankning i aktier #21258
Talaris Therapeutics, Inc. is a cell therapy company operating in the United... Talaris Therapeutics, Inc. is a cell therapy company operating in the United States, currently in its late clinical development stages. Its mission involves pioneering an allogeneic hematopoietic stem cell transplantation strategy designed to revolutionize treatment paradigms for solid organ transplantation, severe autoimmune conditions, and significant non-malignant blood, immune, and metabolic disorders. The company's flagship product, FCR001, is an innovative allogeneic cell therapy presently in Phase II clinical trials for patients undergoing living donor kidney transplantation. Beyond this, Talaris Therapeutics is actively advancing FCR002 for use in deceased donor kidney transplants, investigating FCR001 for individuals with a severe form of scleroderma, and exploring its applicability for a range of other serious non-malignant blood, immune, or metabolic conditions. Founded in 1988, the company maintains its headquarters in Louisville, Kentucky.
Aktiekurs
$2.72
Senast synkroniserad: 2023-10-19
Marknadsvärde
$111.47M
Förändring (1 dag)
-0.73%
Förändring (1 år)
0.00%
Land
US
Handel Talaris Therapeutics, Inc. (TALS)

Kategori

Historik för aktiesplit för Talaris Therapeutics, Inc. (TALS)
Aktien Talaris Therapeutics, Inc. (symbol: TALS) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 23, 2026.
En TALS-aktie köpt före Aug 23, 2026 motsvarar nu 0 TALS-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH